Decreased bone formation explains osteoporosis in a genetic mouse model of hemochromatosiss

PLoS ONE

Volumn 11, Issue 2, 2016, Pages

  Doyard, Mathilde ^a,b   Chappard, Daniel ^c   Leroyer, Patricia ^a,b   Roth, Marie Paule ^d   Loréal, Olivier ^a,b,e   Guggenbuhl, Pascal ^a,b,f  

^a INSERM   (France)

^b UNIVERSITÉ DE RENNES 1   (France)

^c ANGERS UNIVERSITY HOSPITAL   (France)

^d University of Toulouse III   (France)

^e PONTCHAILLOU UNIVERSITY HOSPITAL   (France)

^f SERVICE DE RHUMATOLOGIE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE MASS; CONTROLLED STUDY; GENE MUTATION; GENETIC PREDISPOSITION; HEMOCHROMATOSIS; IN VITRO STUDY; IRON OVERLOAD; MALE; MOLECULAR MECHANICS; MORPHOMETRICS; MOUSE; NONHUMAN; OSSIFICATION; OSTEOBLAST; OSTEOLYSIS; OSTEOPOROSIS; PHENOTYPE; ANIMAL; BONE; BONE DEVELOPMENT; BONE MINERALIZATION; COMPLICATION; DEFICIENCY; DISEASE MODEL; GENETICS; KNOCKOUT MOUSE; LIVER; METABOLISM; PATHOLOGY;

HEMOCHROMATOSIS PROTEIN; HFE PROTEIN, MOUSE; HLA ANTIGEN CLASS 1; IRON; MEMBRANE PROTEIN;

ANIMALS; BONE AND BONES; CALCIFICATION, PHYSIOLOGIC; DISEASE MODELS, ANIMAL; HEMOCHROMATOSIS; HEMOCHROMATOSIS PROTEIN; HISTOCOMPATIBILITY ANTIGENS CLASS I; IRON; LIVER; MALE; MEMBRANE PROTEINS; MICE; MICE, KNOCKOUT; OSTEOGENESIS; OSTEOPOROSIS;

EID: 84959144862     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0148292     Document Type: Article

References (43)

1. Brissot P, Bardou-Jacquet E, Latournerie M, Ropert-Bouchet M, Island ML, Loreal O et al. Hereditary iron overload. Pathol Biol 2010; 58:316-23. doi: 10.1016/j.patbio.2009.10.011 PMID: 19942367
2. Pietrangelo A & Trautwein C. Mechanisms of disease: The role of hepcidin in iron homeostasis-implications for hemochromatosis and other disorders. Nat Clin Pract Gastroenterol Hepatol 2004; 1:39-45. PMID: 16265043
3. Brissot P, Le Lan C, Troadec MB, Lorho R, Ropert M, Lescoat G et al. HFE hemochromatosis: pathogenic and diagnostic approach. Transfus Clin Biol 2005; 12:77-82. PMID: 15925529
4. Guggenbuhl P, Brissot P & Loreal O. Miscellaneous non-inflammatory musculoskeletal conditions. Haemochromatosis: the bone and the joint. Best Pract Res Clin Rheumatol 2011; 25:649-64. doi: 10. 1016/j.berh.2011.10.014 PMID: 22142745
5. Consensus development conference: diagnosis, prophylaxis, and treatment of osteoporosis. Am J Med 1993; 94:646-50. PMID: 8506892
6. Lespessailles E, Gadois C, Lemineur G, Do-Huu JP & Benhamou L. Bone texture analysis on direct digital radiographic images: precision study and relationship with bone mineral density at the os calcis. Calcif Tissue Int 2007; 80: 97-102. PMID: 17308991
7. Rachidi M, Marchadier A, Gadois C, Lespessailles E, Chappard C & Benhamou CL. Law's masks descriptors applied to bone texture analysis: an innovative and discriminant tool in osteoporosis. Skeletal Radiol 2008; 37:541-48. doi: 10.1007/s00256-008-0463-2 PMID: 18327577
8. Sinigaglia L, Fargion S, Fracanzani AL, Binelli L, Battafarano N, Varenna M et al. Bone and joint involvement in genetic hemochromatosis: role of cirrhosis and iron overload. J Rheumatol 1997; 24:1809-13. PMID: 9292808
9. Guggenbuhl P. Osteoporosis in males and females: Is there really a difference? Joint Bone Spine 2009; 76:595-601. doi: 10.1016/j.jbspin.2009.10.001 PMID: 19926512
10. Valenti L, Varenna M, Fracanzani AL, Rossi V, Fargion S & Sinigaglia L. Association between iron overload and osteoporosis in patients with hereditary hemochromatosis. Osteoporos Int 2009; 20:549-55. doi: 10.1007/s00198-008-0701-4 PMID: 18661088
11. Jensen CE, Tuck SM, Agnew JE, Koneru S, Morris RW, Yardumian A, Prescott E, Hoffbrand AV & Wonke B. High prevalence of low bone mass in thalassaemia major. Br J Haematol 1998; 103:911-915. PMID: 9886300
12. Mahachoklertwattana P, Chuansumrit A, Sirisriro R, Choubtum L, Sriphrapradang A & Rajatanavin R. Bone mineral density, biochemical and hormonal profiles in suboptimally treated children and adolescents with beta-thalassaemia disease. Clin Endocrinol 2003; 58:273-79.
13. Mahachoklertwattana P, Sirikulchayanonta V, Chuansumrit A, Karnsombat P, Choubtum L, Sriphrapradang A et al. Bone histomorphometry in children and adolescents with beta-thalassemia disease: ironassociated focal osteomalacia. J Clin Endocrinol Metab 2003; 88:3966-72. PMID: 12915694
14. Karimi M, Ghiam AF, Hashemi A, Alinejad S, Soweid M & Kashef S. Bone mineral density in beta-thalassemia major and intermedia. Indian Pediatr 2007; 44:29-32. PMID: 17277428
15. Jian J, Pelle E & Huang X. Iron and menopause: does increased iron affect the health of postmenopausal women? Antioxid Redox Signal 2009; 11:2939-43. doi: 10.1089/ARS.2009.2576 PMID: 19527179
16. Pawlotsky Y, Lancien Y, Roudier G, Hany Y, Louboutin JY, Ferrand B et al. Bone histomorphometry and osteo-articular manifestations of idiopathic hemochromatosis. Rev Rhum Mal Osteoartic 1989; 46:91-9.
17. Conte D, Caraceni MP, Duriez J, Mandelli C, Corghi E, Cesana M et al. Bone involvement in primary hemochromatosis and alcoholic cirrhosis. Am J Gastroenterol 1989; 84:1231-4. PMID: 2801672
18. Messer JG, Kilbarger AK, Erikson KM & Kipp DE. Iron overload alters iron-regulatory genes and proteins, down-regulates osteoblastic phenotype, and is associated with apoptosis in fetal rat calvaria cultures. Bone 2009; 45:972-979. doi: 10.1016/j.bone.2009.07.073 PMID: 19643212
19. Yamasaki K & Hagiwara H. Excess iron inhibits osteoblast metabolism. Toxicol Lett 2009; 191:211-5. doi: 10.1016/j.toxlet.2009.08.023 PMID: 19735707
20. Yang Q, Jian J, Abramson SB & Huang X. Inhibitory effects of iron on bone morphogenetic protein-2-induced osteoblastogenesis. J Bone Miner Res 2011; 26:1188-96. doi: 10.1002/jbmr.337 PMID: 21308772
21. Doyard M, Fatih N, Monnier A, Island ML, Aubry M, Leroyer P et al. Iron excess limits HHIPL-2 gene expression and decreases osteoblastic activity in human MG-63 cells. Osteoporos Int 2012; 23:2435-45. doi: 10.1007/s00198-011-1871-z PMID: 22237814
22. Guggenbuhl P, Filmon R, Mabilleau G, Basle MF & Chappard D. Iron inhibits hydroxyapatite crystal growth in vitro. Metabolism 2008; 57:903-10. doi: 10.1016/j.metabol.2008.02.004 PMID: 18555830
23. de Vernejoul MC, Pointillart A, Golenzer CC, Morieux C, Bielakoff J, Modrowski D et al. Effects of iron overload on bone remodeling in pigs. Am J Pathol 1984; 116:377-84. PMID: 6476075
24. Matsushima S, Hoshimoto M, Torii M, Ozaki K & Narama I. Iron lactate-induced osteopenia in male Sprague-Dawley rats. Toxicol Pathol 2001; 29:623-9. PMID: 11794378
25. Kudo H, Suzuki S, Watanabe A, Kikuchi H, Sassa S, Sakamoto S et al. Effects of colloidal iron overload on renal and hepatic siderosis and the femur in male rats. Toxicology 2008; 246:143-7. doi: 10.1016/j. tox.2008.01.004 PMID: 18289763
26. Guggenbuhl P, Fergelot P, Doyard M, Libouban H, Roth MP, Gallois Y et al. Bone status in a mouse model of genetic hemochromatosis. Osteoporos Int 2011; 22:2313-9. doi: 10.1007/s00198-010-1456-2 PMID: 20976594
27. McDermott JH & Walsh CH. Hypogonadism in hereditary hemochromatosis. J Clin Endocrinol Metab 2005; 90:2451-5. PMID: 15657376
28. Barry M & Sherlock S. Measurement of liver-iron concentration in needle-biopsy specimens. Lancet 1971; 1:100-3. PMID: 4099600
29. Chappard D, Legrand E, Pascaretti C, Basle MF & Audran M. Comparison of eight histomorphometric methods for measuring trabecular bone architecture by image analysis on histological sections. Microsc Res Tech 1999; 45:303-12. PMID: 10383123
30. Chuang PT & McMahon AP. Vertebrate Hedgehog signalling modulated by induction of a Hedgehogbinding protein. Nature 1999; 397:617-621. PMID: 10050855
31. Plaisant M, Fontaine C, Cousin W, Rochet N, Dani C & Peraldi P. Activation of hedgehog signaling inhibits osteoblast differentiation of human mesenchymal stem cells. Stem Cells 2009; 27:703-13. doi: 10.1634/stemcells.2008-0888 PMID: 19096040
32. Oliveira F, Bellesini L, Defino H, da Silva Herrero C, Beloti M & Rosa A. Hedgehog signaling and osteoblast gene expression are regulated by purmorphamine in human mesenchymal stem cells. J Cell Biochem 2012; 113:204-8. doi: 10.1002/jcb.23345 PMID: 21898541
33. Jensen CE, Tuck SM, Agnew JE, Koneru S, Morris RW, Yardumian A et al. High incidence of osteoporosis in thalassaemia major. J Pediatr Endocrinol Metab 1998; 11 Suppl 3: 975-7. PMID: 10091176
34. Vichinsky EP. The morbidity of bone disease in thalassemia. Ann N Y Acad Sci 1998; 850: 344-8. PMID: 9668556
35. Vogiatzi MG, Autio KA, Mait JE, Schneider R, Lesser M & Giardina PJ. Low bone mineral density in adolescents with beta-thalassemia. Ann N Y Acad Sci 2005; 1054:462-6. PMID: 16339698
36. Shamshirsaz AA, Bekheirnia MR, Kamgar M, Pakbaz Z, Tabatabaie SM, Bouzari N, et al. Bone mineral density in Iranian adolescents and young adults with beta-thalassemia major. Pediatr Hematol Oncol 2007; 24:469-79. PMID: 17786783
37. Vogiatzi MG, Macklin EA, Fung EB, Vichinsky E, Olivieri N, Kwiatkowski J et al. Prevalence of fractures among the Thalassemia syndromes in North America. Bone 2006; 38:571-5. PMID: 16298178
38. Vogiatzi MG, Macklin EA, Fung EB, Cheung AM, Vichinsky E, Olivieri N et al. Bone disease in thalassemia: a frequent and still unresolved problem. J Bone Miner Res 2009; 24:543-57. doi: 10.1359/jbmr. 080505 PMID: 18505376
39. Skordis N, Efstathiou E, Kyriakou A & Toumba M. Hormonal dysregulation and bones in thalassaemiaan overview. Pediatr Endocrinol 2008; Rev 6 Suppl 1:107-15.
40. Tsay J, Yang Z, Ross FP, Cunningham-Rundles S, Lin H, Coleman R et al. Bone loss caused by iron overload in a murine model: importance of oxidative stress. Blood 2010; 116:2582-9. doi: 10.1182/ blood-2009-12-260083 PMID: 20554970
41. Morabito N, Gaudio A, Lasco A, Atteritano M, Pizzoleo MA, Cincotta M et al; Osteoprotegerin and RANKL in the pathogenesis of thalassemia-induced osteoporosis: new pieces of the puzzle. J Bone Miner Res 2004; 19:722-7. PMID: 15068494
42. Voskaridou E & Terpos E. Osteoprotegerin to soluble receptor activator of nuclear factor kappa-B ligand ratio is reduced in patients with thalassaemia-related osteoporosis who receive vitamin D3. Eur J Haematol 2005; 74:359-61. PMID: 15777350
43. Angelopoulos NG, Goula A, Katounda E, Rombopoulos G, Kaltzidou V, Kaltsas D et al. Circulating osteoprotegerin and receptor activator of NF-kappaB ligand system in patients with beta-thalassemia major. J Bone Miner Metab 2007; 25:60-7. PMID: 17187195